243 related articles for article (PubMed ID: 22864740)
21. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
22. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
Jug M; Maestrelli F; Bragagni M; Mura P
J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
[TBL] [Abstract][Full Text] [Related]
23. Preformulation studies of novel 5'-O-carbonates of lamivudine with biological activity: solubility and stability assays.
Gualdesi MS; Ravetti S; Raviolo MA; Briñón MC
Drug Dev Ind Pharm; 2014 Sep; 40(9):1246-52. PubMed ID: 23855736
[TBL] [Abstract][Full Text] [Related]
24. Polymorphism in sulfadimidine/4-aminosalicylic acid cocrystals: solid-state characterization and physicochemical properties.
Grossjohann C; Serrano DR; Paluch KJ; O'Connell P; Vella-Zarb L; Manesiotis P; Mccabe T; Tajber L; Corrigan OI; Healy AM
J Pharm Sci; 2015 Apr; 104(4):1385-98. PubMed ID: 25605031
[TBL] [Abstract][Full Text] [Related]
25. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
Zahedi P; Lee PI
Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
[TBL] [Abstract][Full Text] [Related]
26. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
Lee PS; Han JY; Song TW; Sung JH; Kwon OS; Song S; Chung YB
Int J Pharm; 2006 Jun; 316(1-2):29-36. PubMed ID: 16574357
[TBL] [Abstract][Full Text] [Related]
27. Disproportionation of a crystalline citrate salt of a developmental pharmaceutical compound: characterization of the kinetics using pH monitoring and online Raman spectroscopy plus quantitation of the crystalline free base form in binary physical mixtures using FT-Raman, XRPD and DSC.
Skrdla PJ; Zhang D
J Pharm Biomed Anal; 2014 Mar; 90():186-91. PubMed ID: 24378612
[TBL] [Abstract][Full Text] [Related]
28. Solvent-mediated amorphous-to-crystalline transformation of nitrendipine in amorphous particle suspensions containing polymers.
Xia D; Wu JX; Cui F; Qu H; Rades T; Rantanen J; Yang M
Eur J Pharm Sci; 2012 Aug; 46(5):446-54. PubMed ID: 22484330
[TBL] [Abstract][Full Text] [Related]
29. Tris(hydroxymethyl) aminomethane salt of ramipril: synthesis, structural characterization from X-ray powder diffraction and stability studies.
Bhattacharya A; Chattopadhyay B; Chakraborty S; Roy BN; Singh GP; Godbole HM; Rananaware UB; Mukherjee AK
J Pharm Biomed Anal; 2012 Nov; 70():280-7. PubMed ID: 22877875
[TBL] [Abstract][Full Text] [Related]
30. Photo-polymeriable chitosan derivative prepared by Michael reaction of chitosan and polyethylene glycol diacrylate (PEGDA).
Ma G; Zhang X; Han J; Song G; Nie J
Int J Biol Macromol; 2009 Dec; 45(5):499-503. PubMed ID: 19720075
[TBL] [Abstract][Full Text] [Related]
31. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
32. Crystal structure and physicochemical properties of crystalline form of 2'-O-{3-[(7-chloro-4-quinolinyl)amino]propyl}-9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin A.
Filić D; Starčević K; Pešić D; Jurmanović S; Meenan E; Spezzaferri A; Đilović I; Prugovečki B
J Pharm Sci; 2011 Jul; 100(7):2586-98. PubMed ID: 21394721
[TBL] [Abstract][Full Text] [Related]
33. Supercritical fluid assisted atomization introduced by an enhanced mixer for micronization of lysozyme: Particle morphology, size and protein stability.
Du Z; Guan YX; Yao SJ; Zhu ZQ
Int J Pharm; 2011 Dec; 421(2):258-68. PubMed ID: 22001535
[TBL] [Abstract][Full Text] [Related]
34. Characterisation, solubility and intrinsic dissolution behaviour of benzamide: dibenzyl sulfoxide cocrystal.
Grossjohann C; Eccles KS; Maguire AR; Lawrence SE; Tajber L; Corrigan OI; Healy AM
Int J Pharm; 2012 Jan; 422(1-2):24-32. PubMed ID: 22020274
[TBL] [Abstract][Full Text] [Related]
35. Dissolution rate of furosemide from polyethylene glycol solid dispersions.
Ozdemir N; Ordu S
Farmaco; 1997 Oct; 52(10):625-9. PubMed ID: 9507675
[TBL] [Abstract][Full Text] [Related]
36. Dually responsive injectable hydrogel prepared by in situ cross-linking of glycol chitosan and benzaldehyde-capped PEO-PPO-PEO.
Ding C; Zhao L; Liu F; Cheng J; Gu J; Dan S; Liu C; Qu X; Yang Z
Biomacromolecules; 2010 Apr; 11(4):1043-51. PubMed ID: 20337439
[TBL] [Abstract][Full Text] [Related]
37. Effects of solvents and crystallization conditions on the polymorphic behaviors and dissolution rates of valsartan.
Tran TT; Tran PH; Park JB; Lee BJ
Arch Pharm Res; 2012 Jul; 35(7):1223-30. PubMed ID: 22864745
[TBL] [Abstract][Full Text] [Related]
38. A new formulation concept for drugs with poor water solubility for parenteral application.
Jürgens K; Müller BW
Pharmazie; 2005 Sep; 60(9):665-70. PubMed ID: 16222865
[TBL] [Abstract][Full Text] [Related]
39. Role of a novel pyridostigmine bromide-phospholipid nanocomplex in improving oral bioavailability.
Tan QY; Hu NN; Liu GD; Yin HF; Zhang L; Wang H; Lu LY; Zhang JQ
Arch Pharm Res; 2012 Mar; 35(3):499-508. PubMed ID: 22477197
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of supercritical fluid technology as preparative technique of benzocaine-cyclodextrin complexes--comparison with conventional methods.
Al-Marzouqi AH; Jobe B; Dowaidar A; Maestrelli F; Mura P
J Pharm Biomed Anal; 2007 Jan; 43(2):566-74. PubMed ID: 17010552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
